| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |